Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new strategic partnership between Fiocruz and The Global Health Network will amplify the impact of Fiocruz’s health research and capacity development initiatives by promoting research capacity building across Portuguese-speaking countries, and enabling research findings from the Zika outbreak to benefit public health worldwide.

Composite photo of the Signing of the agreement between The Global Health Network and Fiocruz - plus a group photo

Fiocruz, one of the world’s leading public health institutions and Brazil’s institute for health science and technology, has signed an agreement with The Global Health Network at the University of Oxford to enable evidence generated from research to drive improvements in global health in the most resource-poor and hard to reach areas of the globe.

This new partnership will:

  • Establish a knowledge sharing hub for Fiocruz, embedded within The Global Health Network. This hub will enhance the visibility of Fiocruz’s research and capacity development activities on this global platform. It will both connect existing partners and promote new partnerships, inviting the rest of the world to learn from and benefit from their advances. 
  • Promote research capacity building across Portuguese-speaking countries. With an initial focus on Angola, followed by Mozambique, Fiocruz and The Global Health Network will collaborate with local research organisations to promote access to training, support, tools and resources for local health works – all in Portuguese. This aims to overcome language as a barrier to conducting research, giving health workers the skills and training to build their career through research experience.
  • Share research findings and recommendations from the Zika outbreak. A knowledge sharing hub will consolidate and communicate findings from the three Zika research consortia to health workers, research teams and, most importantly, the families impacted by this devastating outbreak. It will provide a powerful mechanism for sharing the findings and helping these results get back to the community, local health delivery teams and into practice to make a lasting impact. Through sharing recommendations arising from research during the outbreak, the results can be used for public health benefit and, over time, become an integral part of vector control activities. This is an important outcome for ZikaPLAN and ZIKAction*, and for ZIKAlliance an opportunity to contribute by sharing information that can be useful for feeding the platform.

Fiocruz has a long history of embedding health research into health systems and building research capacity through equipping health workers with the skills to put research results into practice and generate evidence, with outcomes that improve the lives of their communities. The Global Health Network brings its extensive experience in knowledge sharing and communities of practice to amplify the impact of Fiocruz’s work on a global scale.

A shared ethos between Fiocruz and The Global Health Network underpins this partnership: firstly, that public health can be improved through research and, secondly, in which the advances from each programme enriches the others. By building capacity for research across the globe, evidence can be generated where such data is missing, across diseases, geographies and communities, and the impacts of this research can be accelerated when methods, best practice and experience are shared.

About The Global Health Network

More, better and faster research is critical to solving the world’s biggest health challenges. The Global Health Network is sharing knowledge, methods and tools between disease areas, regions and organisations to amplify evidence generation. Research teams and professionals are being trained and supported to lead and undertake health research in the world’s most challenging settings. This is achieved by applying the best digital technology and harnessing the sharing phenomena, working virtually and on the ground to enable the capture of life-saving data.

About Fiocruz

Fiocruz is the most prominent Institution of Science and Technology in Health in Latin America, whose mission is to produce, disseminate and share knowledge and technologies, aiming at strengthening and consolidating the Unified Health System and the promotion of health and quality of life for the population

Funding

Eu flag *This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No.s 734584, 734857.

Similar stories

A new WWARN study supports safety of WHO recommended malaria treatment to advance elimination and reduce spread of artemisinin resistance

A new WWARN study, published in BMC Medicine, supports a World Health Organization (WHO) recommendation that a single primaquine target dose of 0.25 mg/kg is generally safe and well tolerated when given together with an ACT to treat malaria.

Routine surveillance data can provide an early warning system for antimalarial resistance in pre-elimination areas in Africa

In the first published study of its kind, a new WWARN paper in the Malaria Journal has created near-real-time maps to support antimalarial drug resistance monitoring, using routine malaria surveillance data and individually patient linked data on molecular markers of antimalarial drug resistance.

Oxford University launch new clinical trial to test a treatment for monkeypox

The team behind the world-leading RECOVERY trial of COVID-19 treatments are leading a new study investigating a potential treatment for people who have been diagnosed with monkeypox. The National Institute for Health and Care Research (NIHR) has commissioned and funded the study. The first patients have now been recruited.

Using mathematical modelling to fight malaria

Researchers have created a mathematical model to predict genetic resistance to antimalarial drugs in Africa to manage one of the biggest threats to global malarial control.

FORESFA and VIE project meetings

The Medicine Quality Research Group organised a multidisciplinary hybrid meeting at Keble College, Oxford, July 3 to 6, for the FORESFA project ‘Forensic epidemiology and impact of substandard and falsified antimicrobials on public health’, funded by a Wellcome Collaborative Award.

Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis

Patients affected by COVID-19 should be treated according to the severity of their disease. However, not all key national or international organisations define severity in the same way. This imprecision in severity assessment compromises the validity of some therapeutic recommendations. Using individual patient data would better guide and improve therapeutic recommendations for COVID-19.